BLAIR WILLIAM & CO/IL - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$6,031,696
-19.1%
132,886
+0.0%
0.02%
-14.8%
Q2 2023$7,460,164
+27.6%
132,885
+2.8%
0.03%
+17.4%
Q1 2023$5,844,394
+80.6%
129,215
+62.3%
0.02%
+64.3%
Q4 2022$3,235,455
-40.1%
79,593
-3.7%
0.01%
-44.0%
Q3 2022$5,404,000
+10.6%
82,691
+2.8%
0.02%
+13.6%
Q2 2022$4,888,000
-31.9%
80,432
-29.6%
0.02%
-12.0%
Q1 2022$7,176,000
+2.9%
114,324
+24.2%
0.02%
+13.6%
Q4 2021$6,973,000
-34.3%
92,022
-3.0%
0.02%
-38.9%
Q3 2021$10,613,000
-25.2%
94,821
+8.2%
0.04%
-26.5%
Q2 2021$14,186,000
+44.7%
87,629
+8.9%
0.05%
+32.4%
Q1 2021$9,806,000
-9.6%
80,472
+13.6%
0.04%
-7.5%
Q4 2020$10,846,000
+86.2%
70,835
+1.7%
0.04%
+60.0%
Q3 2020$5,826,000
+19.7%
69,656
+5.2%
0.02%
+8.7%
Q2 2020$4,868,000
+70.9%
66,243
-1.4%
0.02%
+27.8%
Q1 2020$2,848,000
-33.8%
67,153
-4.9%
0.02%
-18.2%
Q4 2019$4,299,000
+75.8%
70,578
+18.3%
0.02%
+57.1%
Q3 2019$2,445,000
-15.7%
59,650
-3.1%
0.01%
-17.6%
Q2 2019$2,899,000
+432.9%
61,550
+304.0%
0.02%
+466.7%
Q1 2019$544,000
+25.9%
15,235
+0.7%
0.00%0.0%
Q4 2018$432,000
-30.1%
15,135
+8.6%
0.00%
-25.0%
Q3 2018$618,000
-33.0%
13,935
-11.2%
0.00%
-33.3%
Q2 2018$922,000
+30.0%
15,698
+1.3%
0.01%
+20.0%
Q1 2018$709,000
+156.0%
15,5000.0%0.01%
+150.0%
Q3 2017$277,00015,5000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$27,989,04633.20%
Gilfoyle Management LLC 100$4,84215.90%
NEA Management Company, LLC 1,587,854$89,142,1246.80%
ARK Investment Management 7,338,447$411,980,3942.73%
Nikko Asset Management Americas, Inc. 3,533,357$198,327,3282.09%
Del-Sette Capital Management, LLC 33,661$1,889,7291.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Ikarian Capital, LLC 200,000$11,228,0001.79%
Merlin Capital, Inc 8,802$494,1441.67%
Green Alpha Advisors, LLC 34,373$1,929,7001.27%
View complete list of CRISPR THERAPEUTICS AG shareholders